Cas:6018-27-5 D-Arabinitol – L-arabinitol (1:1) manufacturer & supplier

Chemical Name:D-Arabinitol – L-arabinitol (1:1)

CAS.NO:6018-27-5

Synonyms:D-Arabinitol – L-arabinitol (1:1);D,L-arabinitol;Benzeneacetonitrile,a-aMino;DL-aminophenylacetonitrile;2-Amino-2-phenyl-acetonitrile;D-Arabinitol, compd. with L-arabinitol (1:1)

Molecular Formula:C₅H₁₂O₅

Molecular Weight:304.292

HS Code:2905499000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:494.5ºC at 760 mmHg

Density:1.525 g/cm3

Index of Refraction:

PSA:101.15000

Exact Mass:304.136932

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like D-Arabinitol – L-arabinitol (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-Arabinitol, compd. with L-arabinitol (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,D-Arabinitol, compd. with L-arabinitol (1:1) Use and application,Benzeneacetonitrile,a-aMino technical grade,usp/ep/jp grade.

Related News: The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment. D-Arabinitol – L-arabinitol (1:1) manufacturer Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. D-Arabinitol – L-arabinitol (1:1) supplier The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally. D-Arabinitol – L-arabinitol (1:1) vendor The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment. D-Arabinitol – L-arabinitol (1:1) factory Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule.